about
Skeletal muscle PGC-1α is required for maintaining an acute LPS-induced TNFα responseXanthine oxidase in human skeletal muscle following eccentric exercise: a role in inflammationCalcium signalling in the regulation of PGC-1alpha, PDK4 and HKII mRNA expressionAdenosine A 2B receptors modulate cAMP levels and induce CREB but not ERK1/2 and p38 phosphorylation in rat skeletal muscle cellsAttenuated purinergic receptor function in patients with type 2 diabetes.Anaerobic energy expenditure and mechanical efficiency during exhaustive leg press exercise.Energy metabolism during repeated sets of leg press exercise leading to failure or notEffect of nitric oxide synthase inhibition on the exchange of glucose and fatty acids in human skeletal muscle.Effect of extraluminal ATP application on vascular tone and blood flow in skeletal muscle: implications for exercise hyperemia.Effect of endurance versus resistance training on quadriceps muscle dysfunction in COPD: a pilot studyAngiogenic response to passive movement and active exercise in individuals with peripheral arterial disease.Capillary growth in human skeletal muscle: physiological factors and the balance between pro-angiogenic and angiostatic factors.What turns off the angiogenic switch in skeletal muscle?Cardiovascular Adaptations to Exercise Training.Effect of PDE5 inhibition on the modulation of sympathetic α-adrenergic vasoconstriction in contracting skeletal muscle of young and older recreationally active humans.Potentiation of cGMP signaling increases oxygen delivery and oxidative metabolism in contracting skeletal muscle of older but not young humans.Increased skeletal muscle capillarization enhances insulin sensitivity.Regulation of VEGF and bFGF mRNA expression and other proliferative compounds in skeletal muscle cells.Pro- and anti-angiogenic factors in human skeletal muscle in response to acute exercise and training.Endothelial mechanotransduction proteins and vascular function are altered by dietary sucrose supplementation in healthy young male subjects.Resveratrol modulates the angiogenic response to exercise training in skeletal muscles of aged men.Interstitial and plasma adenosine stimulate nitric oxide and prostacyclin formation in human skeletal muscle.Contraction-induced secretion of VEGF from skeletal muscle cells is mediated by adenosine.Low blood flow at onset of moderate-intensity exercise does not limit muscle oxygen uptake.Comparison of exogenous adenosine and voluntary exercise on human skeletal muscle perfusion and perfusion heterogeneity.Muscle interstitial ATP and norepinephrine concentrations in the human leg during exercise and ATP infusion.Effect of fiber type and nutritional state on AICAR- and contraction-stimulated glucose transport in rat muscle.Physical activity opposes the age-related increase in skeletal muscle and plasma endothelin-1 levels and normalizes plasma endothelin-1 levels in individuals with essential hypertension.Exercise-induced increase in interstitial bradykinin and adenosine concentrations in skeletal muscle and peritendinous tissue in humans.Localization and function of ATP-sensitive potassium channels in human skeletal muscle.Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle.Cytochrome P450 2C9 plays an important role in the regulation of exercise-induced skeletal muscle blood flow and oxygen uptake in humans.Reply from Lasse Gliemann, Jakob Schmidt, Jesper Olesen, Rasmus Sjørup Biensø, Sebastian Louis Peronard, Simon Udsen Grandjean, Stefan Peter Mortensen, Michael Nyberg, Jens Bangsbo, Henriette Pilegaard and Ylva Hellsten.Exercise but not prostanoids enhance levels of vascular endothelial growth factor and other proliferative agents in human skeletal muscle interstitium.Indication of in vivo xanthine oxidase activity in human skeletal muscle during exercise.Formation of hydrogen peroxide and nitric oxide in rat skeletal muscle cells during contractions.Effect of ribose supplementation on resynthesis of adenine nucleotides after intense intermittent training in humans.Lifelong physical activity prevents an age-related reduction in arterial and skeletal muscle nitric oxide bioavailability in humans.Subcellular localization and mechanism of secretion of vascular endothelial growth factor in human skeletal muscle.Probenecid Inhibits α-Adrenergic Receptor-Mediated Vasoconstriction in the Human Leg Vasculature.
P50
Q21134754-18EC90F2-404B-4F02-90DE-14AFA47CB356Q24530189-937ADE68-4DB5-47D4-AADD-73209C05A8BDQ28569385-8C3AC60C-8ABB-4B13-8546-28C1952A0EF7Q28581016-6EE0C13B-00A3-4747-9CE8-DB82A5FFEFFEQ33556510-95B4F5A3-F66F-4EB1-949C-4CD81C0EA86BQ33728230-B58550C5-FDA9-4495-B204-CF0EDE304916Q34342180-09099C8B-8B85-4DAC-86EB-86DD369B0388Q36940489-7C481623-E68B-4045-B17D-8D64FEBBDAB6Q37094164-A81F86BA-5A0F-4CD7-A424-E2E5C82E8829Q37381482-2339CCEE-15A6-4F3B-BE96-4A97639D3E0CQ37441971-8DE6E59E-88E5-45EC-B5C9-D436C3FC5BFDQ38268455-0D76E79C-8313-417D-B0EF-0FE88DA7395CQ38541097-D167DA79-5968-495C-B48A-F0D11A07FAD0Q38693262-0C39CFF9-F033-454E-8679-C92528449886Q40967921-757F662A-AB55-45F1-8269-569116DCB9A2Q41052616-96D36C42-6537-4193-83DE-3055EFC390A3Q41685853-F729C27F-1A15-48C2-9B93-9A3E3632E13EQ42472054-6539F04A-8B91-49B5-9190-99B1B4024A6EQ42498704-53002B90-5ABE-4039-B34F-E7167F87C64AQ42511108-B3372722-C87E-4CCC-B899-5CEFC29B55D9Q42704468-3162BD34-380D-4B6B-B25F-5FDC4A5F36FCQ42839697-871F090B-3096-4A25-A8C7-9A9C8A356E30Q43027450-AF514ED1-3F08-436D-AE49-797B6D5C16EEQ43188273-EBA2706E-7535-4A6A-B5DE-E05A0A9867A8Q43235355-71E3C7A5-A7CE-46AE-8119-1C551E27BA9EQ43268360-99A48A50-91B1-4809-BB19-F8C41A75B41EQ43989934-926100B4-1B38-465B-95B9-57370B52E048Q43995561-0F400197-0675-47F0-87E9-119FC7235F63Q44087193-6BB98A59-54DF-4125-B3C9-234BDC37061CQ44185894-82D66534-7A38-4566-982B-20F0E8420834Q44253307-C6C9971B-FD13-47F7-977C-125CD248854DQ44267774-6D91B569-FC43-4434-A41F-9780D8B869CCQ44313615-9F0C805C-96B7-4175-B030-0425BEE0B159Q44445936-F28A7B44-E784-474D-BBD6-B89916837122Q44471348-DC8D143D-ED98-4BE2-849E-1417BE4C3B44Q44555281-4A45BBAE-F5D2-463F-A3E0-71F2A72D3988Q44683396-FA644500-07DA-4F8F-93BE-D305C9F16820Q44738481-7290C656-2CD4-4070-8846-F49735D43C8EQ44908278-A71BDBBB-5780-4148-A627-58088B2FBE30Q45071370-CD379463-F0A7-4218-AC5E-258A4CE82481
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ylva Hellsten
@ast
Ylva Hellsten
@en
Ylva Hellsten
@es
Ylva Hellsten
@sl
type
label
Ylva Hellsten
@ast
Ylva Hellsten
@en
Ylva Hellsten
@es
Ylva Hellsten
@sl
prefLabel
Ylva Hellsten
@ast
Ylva Hellsten
@en
Ylva Hellsten
@es
Ylva Hellsten
@sl
P1053
B-3420-2015
P106
P1153
7004155171
P21
P31
P3829
P496
0000-0002-2435-9558
P569
2000-01-01T00:00:00Z